T1	Participants 133 156	advanced ovarian cancer
T2	Participants 164 267	May 1978 until November 1980, 169 previously untreated patients with advanced epithelial ovarian cancer
T3	Participants 462 565	Eleven patients were excluded from analysis and another 5 patients were excluded from response analysis
